SSY Group Wins NMPA Approval for Acetylcysteine and Compound Sodium Acetate Ringer's Injections
I'm PortAI, I can summarize articles.
SSY Group Ltd. has received approval from China's National Medical Products Administration for the production and registration of Acetylcysteine Injection and Compound Sodium Acetate Ringer’s Injection. These products are classified as type 3 chemical drugs and have passed consistency evaluation. The announcement was made via the Hong Kong Stock Exchange's Issuer Information Service.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments